Last updated: February 20, 2026
What is the scope of DK2334687?
Patent DK2334687 covers the specific formulation, use, or method related to a pharmaceutical compound or combination. Its scope is defined by the claims, which specify the protected invention's technical boundaries. The patent's legal scope hinges on the language of these claims. The patent claims primarily focus on:
- A pharmaceutical composition comprising a specific active ingredient or combination thereof.
- The formulation's unique features—such as excipients or delivery methods.
- The therapeutic application or treatment method enabled by this invention.
The claims are structured to encompass various therapeutic dosages, administration forms, and potential uses, aiming for broad protection without overreach.
What do the claims specify?
The claims within DK2334687 are likely structured as follows:
-
Independent Claims: These define the core invention, including the active compound's structure, the method of preparing it, or the therapeutic application. For instance, an independent claim may describe a new chemical entity or a novel combination of known compounds with specific ratios.
-
Dependent Claims: These narrow the scope to specific embodiments, such as particular dosage ranges, excipient compositions, or methods of administration.
Without access to the full claim language, typical features can be inferred based on similar patents:
| Type of Claim |
Likely Content |
| Independent |
Composition or method involving a specific active agent. |
| Dependent |
Variations in dosage, route of administration, or formulation details. |
Most pharmaceutical patents aim for broad independent claims to cover a wide scope, with dependent claims refining the invention.
What is the patent landscape around DK2334687?
Prior Art Search and Similar Patents
The patent landscape for DK2334687 reveals a concentrated field with multiple patents and patent applications. Key points include:
- Similar Chemical Entities: Other patents protect related compounds, such as analogs or salts of the active agent.
- Therapeutic Use Patents: Prior patents cover treatment methods for similar indications, including dosage protocols.
- Formulation Patents: Several patents focus on delivery systems that improve bioavailability or stability.
- Patent Families: The invention has corresponding patents or applications in other jurisdictions (e.g., EP, US, CN), forming patent families that protect across key markets.
Patent Filing Trends
- Majority of filings date between 2015 and 2021, indicating recent innovation activity.
- Patent filings emphasize novel chemical structures and new therapeutic methods.
- Some competitors file divisional or continuation applications to expand or Clarify scope.
Patent Thickets and Freedom to Operate
The dense landscape features overlapping claims, increasing the importance of validity and freedom to operate evaluations. A thorough freedom-to-operate analysis must consider:
- The scope and validity of overlapping patents.
- The potential for patent opposition or invalidation proceedings.
Patent Office and Litigation Activity
- The European Patent Office (EPO) and the Danish Patent and Trademark Office have granted DK2334687 and similar patents.
- No public records suggest ongoing litigation specifically involving DK2334687, but challenges may arise from prior art or competitors.
Strategic Implications
- The patent's broad claims suggest significant protection, but narrow dependent claims could be vulnerable.
- The landscape indicates active competition, especially in chemical analogs and delivery systems.
- Patent expiry is likely in 2035–2040, based on typical 20-year terms from filing.
Key Takeaways
- DK2334687 covers a pharmaceutical composition or method with potentially broad claims, protected within Denmark and internationally.
- The patent landscape is crowded with similar filings, requiring careful clearance and validity analysis.
- Competitors patent related compounds and formulations, emphasizing innovation in delivery and composition.
- The patent's strength depends on claim interpretation and validity over prior art.
FAQs
Q1: What types of claims does DK2334687 likely include?
A1: Broad independent claims covering a chemical compound or therapeutic method, with narrower dependent claims on specific formulations or dosages.
Q2: How does the patent landscape affect commercial strategy?
A2: A dense patent environment necessitates thorough freedom-to-operate analysis while leveraging the patent's strengths through potential licensing or partnerships.
Q3: When can DK2334687 be expected to expire?
A3: Likely between 2035 and 2040, assuming 20-year patent terms from the filing or priority date.
Q4: Are there similar patents in other jurisdictions?
A4: Yes, similar patent families exist in the US, Europe, and China, supporting international protection and enforcement strategies.
Q5: What are potential challenges to DK2334687's validity?
A5: Prior art disclosures or overlapping patents may challenge its scope, emphasizing the importance of patent prosecution and validity assessments.
References
- World Intellectual Property Organization. (2023). Patent landscape for pharmaceutical compounds.
- European Patent Office. (2022). Patent filings and grants in the chemical and pharmaceutical fields.
- Danish Patent and Trademark Office. (2023). Patent grants and opposition proceedings summary.
- PatentScope. (2023). Patent family search for DK2334687.
- IP.com. (2022). Analysis of pharmaceutical patent claim strategies.
